Table 2 Correlation between MAGED1-1 expression and clinicopathological characteristics of colorectal cancer patients
From: Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma
Characteristics | MAGED1-1 | Chi-square test P-value | ||
|---|---|---|---|---|
Low or none No. cases (%) | High No. cases (%) | |||
Gender | Female | 63 (39.1) | 39 (31.5) | 0.213 |
Male | 98 (60.9) | 85 (68.5) | ||
Age (years) | ≤ 50 | 65 (40.4) | 46 (37.1) | 0.625 |
> 50 | 96 (59.6) | 78 (62.9) | ||
Location | colon | 70 (43.5) | 63 (50.8) | 0.233 |
rectal | 91 (56.5) | 61 (49.2) | ||
Clinical Stage | I + II | 35 (21.7) | 73 (58.9) | <0.001 |
III | 60 (68.2) | 28 (31.8) | ||
IV | 66(74.2) | 23(25.8) | ||
T classification | T1 + T2 | 24 (14.9) | 40 (32.3) | 0.001 |
T3 + T4 | 137 (85.1) | 84 (67.4) | ||
N classification | No | 43 (26.7) | 80 (64.5) | <0.001 |
Yes | 118 (73.3) | 44 (35.5) | ||
M classification | M0 | 95 (59.0) | 101 (81.5) | <0.001 |
M1 | 66 (41.0) | 23 (18.5) | ||
Pathologic Differentiation | Poor | 44 (27.3) | 14 (11.3) | 0.002 |
Moderate | 108 (67.1) | 97 (78.2) | ||
Well | 9 (5.6) | 13 (10.5) | ||
Histological Types | Non-mucinous adenocarcinoma | 148 (92.5) | 120 (96.0) | 0.227 |
mucinous adenocarcinoma | 12 (7.5) | 5(4.0) | ||